Quick Answer
Genpact LTD reported Cash and Equivalents of $853.84 million for fiscal year 2025.
Genpact LTD Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $853.84M | +31.7% |
| 2024 | $648.25M | +11.1% |
| 2023 | $583.67M | -9.8% |
| 2022 | $646.76M | -28.1% |
| 2021 | $899.46M | +32.2% |
| 2020 | $680.44M | +45.7% |
| 2019 | $467.10M | +26.8% |
| 2018 | $368.40M | -27.0% |
| 2017 | $504.47M | +19.4% |
| 2016 | $422.62M | -6.3% |
| 2015 | $450.91M | -2.4% |
| 2014 | $461.79M | -19.2% |
| 2013 | $571.28M | +24.4% |
| 2012 | $459.23M | +12.6% |
| 2011 | $408.02M | +1.0% |
| 2010 | $404.03M | +39.9% |
| 2009 | $288.73M | +56.9% |
| 2008 | $184.05M | -34.1% |
| 2007 | $279.31M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $740.76M | -27.6% | +11.7% |
| June 30, 2025 | $663.26M | -27.4% | +18.1% |
| March 31, 2025 | $561.62M | +17.4% | -13.4% |
| December 31, 2024 | $648.25M | +11.1% | -36.6% |
| September 30, 2024 | $1.02B | +89.0% | +11.9% |
| June 30, 2024 | $914.17M | +86.1% | +91.1% |
| March 31, 2024 | $478.40M | -13.4% | -18.0% |
| December 31, 2023 | $583.67M | -9.8% | +7.9% |
- Genpact LTD showed an increase of +31.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, Genpact LTD’s cash and equivalents has grown by 205.7% (from $279.31 million to $853.84 million).
- The most recent figure is from Genpact LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: